Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (1093)

Company Market Cap Price
OCUL Ocular Therapeutix, Inc.
DEXTENZA and other retina products are ophthalmology devices sold by the company.
$2.35B
$10.72
-2.90%
NEOG Neogen Corporation
MDS pathogen detection platform and Petrifilm-based environmental testing are diagnostic equipment offerings.
$2.35B
$10.87
+0.65%
EYE National Vision Holdings, Inc.
Utilizes retinal imaging and medical imaging concepts to support ophthalmic diagnostics.
$2.30B
$28.87
-0.59%
WGS GeneDx Holdings Corp.
Laboratory testing services and advisory components of genetic diagnostics.
$2.30B
$80.52
+1.32%
KN Knowles Corporation
Knowles has a significant MedTech / medical device presence via advanced microphones and related audio components used in medical devices.
$2.27B
$25.97
-2.44%
XRAY DENTSPLY SIRONA Inc.
XRAY directly manufactures dental equipment used in clinical practice (imaging, CAD/CAM, etc.), fitting this tag.
$2.24B
$11.29
+0.13%
ACHC Acadia Healthcare Company, Inc.
ACHC operates hospital services focused on behavioral health, including inpatient psychiatric facilities.
$2.22B
$24.38
+1.29%
ZLAB Zai Lab Limited
OPTUNE/Tumor Treating Fields program represents a medical device platform in cancer treatment.
$2.13B
$19.16
-0.60%
OSW OneSpaWorld Holdings Limited
Medi-Spa offerings utilize medical devices and biometrics (e.g., CoolSculpting Elite, Elemis Biotec, LightStim).
$2.12B
$20.56
-1.30%
BHC Bausch Health Companies Inc.
Solta Medical’s aesthetic devices (e.g., Thermage, Fraxel) fall under Medical Devices & Biometrics.
$2.09B
$5.59
-0.62%
ESTA Establishment Labs Holdings Inc.
Motiva implants, tissue expanders, and related breast prosthetic devices are the core product line, i.e., prosthetics & implants.
$2.07B
$69.74
-1.97%
BHE Benchmark Electronics, Inc.
Manufactures Medical Device Components for use in regulated medical devices.
$2.05B
$55.88
-2.54%
SEM Select Medical Holdings Corporation
Direct hospital services provider; SEM's core revenue comes from Hospital Services including inpatient rehabilitation and CIRH.
$2.01B
$16.25
+0.03%
GRAL GRAIL, Inc.
Galleri is a liquid biopsy-based multi-cancer early detection test using cfDNA methylation, the core product.
$1.95B
$52.64
-2.59%
ATEC Alphatec Holdings, Inc.
Alphatec's primary business is spine/orthopedic implants and devices.
$1.93B
$12.54
-3.54%
RXRX Recursion Pharmaceuticals, Inc.
Platform enables laboratory testing and advisory support through data generation and analysis workflows.
$1.90B
$3.60
-0.96%
INSP Inspire Medical Systems, Inc.
Inspire V is a neuromodulation device designed to treat obstructive sleep apnea, representing Inspire's core product category.
$1.87B
$62.41
-2.97%
OMCL Omnicell, Inc.
XT Series automated dispensing systems, XR2 robot, IVX compounding robot are medical devices and biometrics products.
$1.86B
$41.87
+0.82%
AORT Artivion, Inc.
Artivion's core business is manufacturing medical devices and implantable tissues across cardiology and vascular platforms.
$1.82B
$38.06
-1.14%
SGRY Surgery Partners, Inc.
Provides hospital services including acute inpatient and outpatient care across facilities.
$1.82B
$13.93
-1.10%
OGN Organon & Co.
Directly manufactures/markets medical devices (Nexplanon implant and Jada System) used in women's health and obstetric care.
$1.79B
$6.89
+0.29%
VCEL Vericel Corporation
NexoBrid and burn/wound care products place Vericel in the wound care products category.
$1.77B
$34.06
-2.57%
MD Pediatrix Medical Group, Inc.
Provides hospital-based neonatal and maternal-fetal care services (NICU care and maternal-fetal medicine) delivered in hospital settings.
$1.71B
$19.39
-2.46%
BBAI BigBear.ai Holdings, Inc.
VeriScan biometric traveler processing indicates biometrics/biometric sensing offerings.
$1.67B
$3.88
+1.44%
TNDM Tandem Diabetes Care, Inc.
Tandem Diabetes Care manufactures insulin pumps (medical devices) and biometric sensing data integration, a core medical device product line.
$1.59B
$22.99
-1.79%
ENOV Enovis Corporation
Directly produces orthopedic devices and implants used in reconstructive surgery.
$1.58B
$27.93
+0.94%
UFPT UFP Technologies, Inc.
Design and manufacture of customized components and subsystems used in medical devices (foams, films, plastics, fabrics, die-cut parts, and assembly).
$1.57B
$202.60
-0.68%
ATRC AtriCure, Inc.
AtriCure directly manufactures surgical equipment and devices used in operating rooms and minimally invasive cardiac procedures.
$1.54B
$30.29
-2.26%
CTS CTS Corporation
CTS targets medical end-markets with diagnostic/sensor applications; tagged under Medical Devices & Biometrics.
$1.51B
$52.01
+0.15%
NVCR NovoCure Limited
NovoCure's TTFields cancer therapy device (Optune) is a medical device sold to treat cancer, fitting the Medical Devices & Biometrics category.
$1.50B
$13.96
+3.99%
PRCT PROCEPT BioRobotics Corporation
PROCEPT's Aquablation robotic systems are surgical equipment sold for urology procedures.
$1.48B
$25.60
-3.61%
QDEL QuidelOrtho Corporation
QuidelOrtho directly develops diagnostic instruments and platforms (including molecular diagnostics platforms) used in labs, aligning with Diagnostic Equipment.
$1.44B
$21.48
+1.37%
ARDT Ardent Health Partners, LLC
Ardent operates hospitals delivering acute inpatient and related hospital services.
$1.38B
$9.39
-2.59%
AXGN AxoGen, Inc.
Axogen's Avance Nerve Graft and Axoguard nerve-repair products are surgical devices used in peripheral nerve repair.
$1.35B
$28.52
-2.38%
IRMD IRadimed Corporation
IRADIMED monetizes proprietary disposables and consumables for its infusion pumps and monitoring devices, generating recurring revenue.
$1.34B
$101.37
-3.56%
CNMD CONMED Corporation
A large share of revenues comes from single-use disposable medical device products, i.e., consumables.
$1.33B
$41.79
-2.79%
AHCO AdaptHealth Corp.
Provides medical device consumables (masks, tubing, and related CPAP supplies) for home-use devices.
$1.31B
$9.40
-2.74%
EYPT EyePoint Pharmaceuticals, Inc.
Implantable ophthalmic device component due to bioerodible Durasert E delivery system.
$1.24B
$16.75
-6.97%
PLSE Pulse Biosciences, Inc.
Pulse Biosciences develops nsPFA-based medical devices (e.g., CellFX platform) for non-thermal tissue ablation across soft tissue and cardiac indications.
$1.23B
$18.73
+3.51%
NNE Nano Nuclear Energy Inc
Company engages in laboratory testing/advisory services related to nuclear tech development and regulatory readiness.
$1.18B
$26.58
-6.70%
← Previous
1 ... 2 3 4 5 6 ... 11
Next →
Showing page 4 of 11 (1093 total stocks)

Loading company comparison...

Loading research report...

NVCR NovoCure Limited

NovoCure Secures National Reimbursement Approval for Optune Lua in Japan, Expanding NSCLC Treatment Access

Mar 03, 2026
OGN Organon & Co.

Organon Discontinues Preclinical PCOS Candidate from Forendo Portfolio, Tightening Pipeline Focus

Mar 03, 2026
SEM Select Medical Holdings Corporation

Select Medical Holdings to Be Acquired by Consortium Led by Company Executives and Private‑Equity Firm

Mar 03, 2026
NVCR NovoCure Limited

NovoCure Reports Fourth‑Quarter and Full‑Year 2025 Financial Results, Misses Revenue Estimates but Beats EPS

Feb 27, 2026
PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Reports Q4 2025 Results, Misses Revenue and EPS Estimates

Feb 26, 2026
ACHC Acadia Healthcare Company, Inc.

Acadia Healthcare Reports Fourth‑Quarter and 2025 Results, Highlights Revenue Beat and Significant Net Loss

Feb 25, 2026
ATEC Alphatec Holdings, Inc.

Alphatec Holdings Reports Q4 2025 Results, Highlights Positive Free Cash Flow and Valence Platform Launch

Feb 25, 2026
UFPT UFP Technologies, Inc.

UFP Technologies Reports Record 2025 Results, Driven by Strong Medical Sales and Cost Controls

Feb 25, 2026
AXGN AxoGen, Inc.

Axogen Reports Q4 2025 Earnings: Revenue $59.9 Million, Adjusted EPS $0.07, GAAP Loss $0.28

Feb 24, 2026
ESTA Establishment Labs Holdings Inc.

Establishment Labs Beats Q4 2025 EPS Estimate, Reports $64.6 Million Revenue and 2026 Revenue Guidance of $264–$266 Million

Feb 24, 2026
NVCR NovoCure Limited

British Columbia Becomes First Canadian Province to Cover NovoCure’s Tumor Treating Fields for Glioblastoma

Feb 24, 2026
TNDM Tandem Diabetes Care, Inc.

Tandem Diabetes Care Raises $200 Million in Convertible Senior Notes

Feb 24, 2026
OGN Organon & Co.

Organon Secures Global Rights to Sebela’s MIUDELLA Copper IUD

Feb 23, 2026
GRAL GRAIL, Inc.

GRAIL Reports Q4 2025 Earnings: Revenue Beats Estimates, Net Loss Narrows, but NHS‑Galleri Trial Miss Fuels Investor Concerns

Feb 20, 2026
PLSE Pulse Biosciences, Inc.

Pulse Biosciences Reports Q4 2025 Earnings: Revenue and EPS Beat Estimates, Cash Reserves Decline

Feb 20, 2026
TNDM Tandem Diabetes Care, Inc.

Tandem Diabetes Care Beats Q4 2025 Earnings, Raises 2026 Guidance

Feb 20, 2026
MD Pediatrix Medical Group, Inc.

Pediatrix Medical Group Reports Fourth‑Quarter 2025 Earnings: Revenue Beats, EPS Misses, and Raised EBITDA Guidance

Feb 19, 2026
ATRC AtriCure, Inc.

AtriCure Reports Q4 2025 Earnings, Beats EPS Expectations, and Raises 2026 Guidance

Feb 18, 2026
SEM Select Medical Holdings Corporation

Select Medical Extends 25‑Year Partnership with Philadelphia Eagles, Strengthening Delaware Valley Presence

Feb 17, 2026
QDEL QuidelOrtho Corporation

QuidelOrtho Expands Global Immunoassay Portfolio with Lifotronic Supply Agreement

Feb 16, 2026
AORT Artivion, Inc.

Artivion Reports Q4 2025 Earnings: Revenue Misses Estimates, Non‑GAAP EPS Beats Forecast

Feb 13, 2026
INSP Inspire Medical Systems, Inc.

Inspire Medical Systems Reports Q4 2025 Earnings: Strong Beat, Revised 2026 Guidance Amid Coding Clarification

Feb 12, 2026
NVCR NovoCure Limited

NovoCure Secures FDA Approval for Optune Pax® in Locally Advanced Pancreatic Cancer

Feb 12, 2026
OGN Organon & Co.

Organon Reports Q4 2025 Earnings: Revenue Declines, Net Loss, and Guidance for 2026

Feb 12, 2026
QDEL QuidelOrtho Corporation

QuidelOrtho Reports Q4 2025 Results, Beats Revenue and EPS Estimates, Raises FY26 Guidance

Feb 12, 2026
IRMD IRadimed Corporation

IRadimed Reports Record Q4 2025 Earnings, Raises 2026 Guidance

Feb 11, 2026
IRMD IRadimed Corporation

iRadimed Reports Record 2025 Earnings, Raises Dividend, and Projects Strong 2026 Growth

Feb 10, 2026
KN Knowles Corporation

Knowles Reports Strong Q4 2025 Earnings, Sets Optimistic Q1 2026 Outlook

Feb 06, 2026
PLSE Pulse Biosciences, Inc.

Pulse Biosciences Reports 100% 6‑Month Procedural Success in First‑In‑Human Feasibility Study of nPulse Cardiac Catheter

Feb 06, 2026
OMCL Omnicell, Inc.

Omnicell Reports Fiscal 2025 Results: Revenue Up 7%, GAAP Loss, Non‑GAAP EPS Misses Consensus

Feb 05, 2026